Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose ... and now is creating a new category by bringing the first glucose biosensor cleared for use over-the-counter,” said ...

Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and ...

SAN FRANCISCO—After spending the past year extending its portfolio of continuous glucose ... Dexcom is working to move all of its sensors to its 15-day platform, like its Stelo product, and ...

2024--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter glucose biosensor in ...

DXCM, a renowned medical device company and provider of continuous glucose ... In August, DexCom announced the availability of Stelo, the first over-the-counter CGM biosensor in the United States ...

Dexcom’s focus on expanding continuous glucose monitoring access, rolling out new products like the Stelo, and its plans ... include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6 ...